Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
22 hours ago · Bain Capital, LP is one of the world’s leading multi-asset alternative investment firms. With offices on four continents, our global team aligns our interests with those of our investors and partners for lasting impact. ... Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation. Share this page. Media Contacts Scott Lessne / Charlyn ...
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
11 hours ago · Contacts. Media: For Bain Capital (North America): Charlyn Lusk / Scott Lessne Stanton [email protected] / [email protected] (646) 502-3549 / (646) 502-3569 For Bain Capital (Asia-Pacific ...
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
22 hours ago · TOKYO & BOSTON, February 07, 2025--Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ...
Bain Capital to Buy Mitsubishi Chemical's Pharma Business
14 hours ago · Mitsubishi Chemical Group has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a bid to focus on its key chemical businesses. The Japanese chemical company ...
Bain Capital to Buy Mitsubishi Chemical’s Pharma Business
Mitsubishi Chemical 4188-4.18% decrease; red down pointing triangle Group has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a bid to focus on its key ...
Bain to Acquire Mitsubishi Tanabe Pharma in $3.3 Billion Deal
10 hours ago · Private equity firm Bain Capital agreed to acquire Mitsubishi Chemical Group Corp.’s pharmaceutical unit, adding to a dealmaking boom in Japan.. The deal values Mitsubishi Tanabe Pharma Corp. at ...
Bain buys Japanese pharma Mitsubishi Tanabe for $3.4bn
9 hours ago · US investment group Bain Capital has agreed to buy Mitsubishi Tanabe Pharma for JPY 510 billion (around $3.4 billion), setting up one of the largest private equity buyouts in Japan's healthcare ...
Mitsubishi Chemical to sell drug unit to Bain in $3.36 billion deal
14 hours ago · Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 billion) as it ...
Bain buys 340-year-old pharma company to fast-track Japan’s …
14 hours ago · Bain Capital said it had been in conversation with owner Mitsubishi Chemical for ... Bain Capital has placed a $3.3bn bet on a historic shift in Japan’s conservative drugs approval regime by ...
Mitsubishi Chemical sells pharmaceuticals subsidiary to Bain in …
14 hours ago · TOKYO (Reuters) - Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical subsidiary Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 billion) as it seeks to streamline its portfolio.
- Some results have been removed